Noah S. Rozich, MD
Dr. Noah S. Rozich is a surgical oncologist who sees patients at Texas Oncology Surgical Specialists – Webster Deke Slayton Cancer Center in Webster, Texas. He treats patients diagnosed with abdominal, peritoneal, and gastrointestinal cancers including malignant peritoneal mesothelioma.[1]
Dr. Rozich is skilled in multiple procedures including minimally invasive/robotic and open surgeries and the complex compound surgical procedure known as malignant cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. The procedure has proven to extend survival times for patients diagnosed with several abdominal malignancies.
Education and Career
Dr. Rozich earned his medical degree at the University of Wisconsin School of Medicine and Public Health. He then completed an internship and residency in General Surgery as well as a research fellowship in Surgical Oncology at the University of Oklahoma Health Sciences Center. He completed an additional research fellowship in Surgical Oncology at Johns Hopkins University in Baltimore, Maryland, and a fellowship in Complex General Surgical Oncology at St. Luke’s Hospital in Milwaukee, Wisconsin, part of the Aurora Advocate Health Center.[1]
Research
Dr. Rozich is actively involved in pursuing research that supports improved outcomes for patients undergoing surgery for the treatment of abdominal malignancies including neoadjuvant chemotherapy and immunotherapy as well as minimally invasive, robotic, and open surgeries, HIPEC, and other procedures. He hopes for the development of a precision-based, personalized approach to aggressive cancers, including pancreatic and gastric cancers, so that tumor-specific chemotherapy or immune therapy regimens can be applied and patients have the best possible chance of total disease eradication.[1]
His recent publications include:[2]
Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model. Pan Li, Noah Rozich, Jianxin Wang, Junke Wang, Yao Xu, Brian Herbst, Raymond Yu, Stephen Muth, Nan Niu, Keyu Li, Vanessa Funes, Jessica Gai, Arsen Osipov, Barish H Edi…>; Cancer Letters. 2022 Jul 28
CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal Adenocarcinoma. Seyoun Park, Jonathan G. Sham, Satomi Kawamoto, Alex B. Blair, Noah Rozich, Daniel Fadaei Fouladi, Shahab Shayesteh, Ralph H. Hruban, Jin He, Christopher L. Wolfgang, …>; AJR. American Journal of Roentgenology. 2021 Sep 1
Autoimmune Pancreatitis: A Critical Analysis of the Surgical Experience in an Era of Modern Diagnostics. Ammar A. Javed, Michael J. Wright, Ding Ding, Zunaira N. Javed, Mahya Faghih, Noah Rozich, Elliot K. Fishman, William R. Burns, John L. Cameron, Matthew J. Weiss, Jin …>; Pancreas. 2021 Apr 1
